Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▼ −4.0% | ▼ −4.0% | ▲ +19.7% | ▲ +47.2% | ▲ +52.4% | ▲ +87.8% | ▼ −22.2% | ▲ +10.3% |
| Peer average | ▼ −1.4% | ▼ −9.6% | ▼ −7.9% | ▲ +7.4% | ▲ +4.8% | ▲ +87.6% | ▲ +30.7% | — |
| S&P 500 · VOO | ▼ −0.5% | ▼ −2.3% | ▼ −2.2% | ▲ +11.2% | ▲ +11.8% | ▲ +89.5% | ▲ +77.1% | — |
The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. This mirroring occurs before the deduction of the ETF's internal fees and expenses.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2026-06-29 | 2026-07-07 | $0.06 |
| 2025-12-30 | 2026-01-07 | $0.59 |
| 2025-06-27 | 2025-07-07 | $0.03 |
| 2021-12-30 | 2022-01-07 | $0.03 |
| 2020-12-30 | 2021-01-08 | $0.13 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind GNOM.